Little Falls, NJ (PRWEB) July 25, 2006 –-
Sentrx, the leading provider of drug safety services and solutions, announced today that three proven pharmaceutical-industry leaders have joined the company in Business Development and Client Relations positions. The expansion will support the growing number of clients Sentrx serves and the high level of interest in its pharmacovigilance offerings.
Fulfilling the new role of Vice President, Strategic Alliances and Business Development, is Richard Onorato, MBA. Rich has a 25-year record of contributing to the organizational success of healthcare providers, payers, pharmaceutical companies and healthcare technology solutions vendors. He has held management positions in operations, product marketing, and business development for companies such as Advanced Data Systems, Paramore Consulting, WebMD, Shared Medical Systems, and NEIC. Rich will be responsible for enhancing Sentrx drug safety offerings through strategic alliances.
Joining Sentrx as Account Manager is Frank McCabe, RPh, CCP, MBA. Frank has more than 22 years of healthcare industry experience, including 14 years in pharmaceutical sales, sales management and sales operations with GlaxoSmithKline and Innovex. Prior to entering the pharmaceutical industry, Frank spent eight years as a hospital and community practice pharmacist. He has worked with healthcare professionals across a broad range of therapeutic drug classes and treatment modalities and maintains licensure in multiple states. Frank will manage initiation activities and ongoing service delivery for Sentrx clients, ensuring project milestones and performance standards are achieved.
Adding to the strength of the Sentrx sales team is Amy Zastawney, RN, MPH, who joins the company as Director of Strategic Accounts. Amy's experience spans nearly 25 years in client management, business process re-engineering, business development and clinical practice within the healthcare industry. She has been successful in establishing and growing new business for companies such as Private Healthcare Systems, Perceptive Informatics, PHT Corporation and Quintiles. Most recently, Amy was the Regional Director of Business Development for a leading electronic data capture (EDC) solutions vendor. She began her career practicing nursing in several teaching hospitals, frequently participating in clinical trials as a research assistant. Amy will be responsible for meeting the requirements of potential clients with Sentrx capabilities in clinical trial safety, post-marketing safety monitoring, and safety system hosting.
“The demand for our pharmacovigilance services is growing exponentially,” said Joseph Albano, Chief Executive Officer of Sentrx. “In this time-sensitive drug safety business, we must have the capacity to be responsive at every interaction--beginning with the sales process, through contract negotiation and initiation, and continuing with each adverse event report prepared. These proven industry professionals will help Sentrx deliver innovative solutions that exceed client expectations.”
Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies demonstrate the safety of their products and respond rapidly to any potential risks detected. Through its multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled people, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please visit their website at http://www.sentrx.com; or call 1-888-399-8032, extension 261.